Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05250375 · ClinicalTrials.gov registry record
Natural History Study of Mitochondrial Myopathy
A clinical trial of Primary Mitochondrial Disease, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- 1,300
- Enrollment target
- 1
- Study location
NCT05250375: Recruiting study of Primary Mitochondrial Disease, sponsored by Children's Hospital of Philadelphia.
NCT05250375 is a study of Primary Mitochondrial Disease that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 1,300 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05250375, a study of Primary Mitochondrial Disease, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- 1,300 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to develop and validate tools to measure disease course in patients with primary mitochondrial myopathy (PMM). The main aims of this study are: * Development, validation, and optimization of objective outcome measures for mitochondrial myopathy * Defining the natural history of mitochondrial myopathy Researchers will compare data from patients with primary mitochondrial myopathy to healthy controls. Data from healthy controls will also help define normative data for future studies. Participants will perform clinical exams of muscle strength and endurance and will complete surveys.
Primary Outcome
Muscle strength will be measured longitudinally by handheld dynamometry strength assessments to confirm muscle weakness in proximal and distal muscle groups.
Conditions Studied
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2017-03-24 |
| Est. Completion | 2030-03-24 |
What NCT05250375 shows while recruiting
NCT05250375 is an observational study that tracks outcomes without assigning an intervention. Its 1,300 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Primary Mitochondrial Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05250375 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05250375 about?
NCT05250375 is a clinical study titled "Natural History Study of Mitochondrial Myopathy". The goal of this observational study is to develop and validate tools to measure disease course in patients with primary mitochondrial myopathy (PMM). The main aims of this study are: * Development, validation, and optimization of objective outcome measures for mitochondrial myopathy * Defining the...
What is the current status of trial NCT05250375?
This trial is currently recruiting. The enrollment target is 1,300 participants. The study started on 2017-03-24. Estimated completion is 2030-03-24.
What conditions does trial NCT05250375 study?
This clinical trial studies the following conditions: Primary Mitochondrial Disease.
Who is sponsoring clinical trial NCT05250375?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05250375 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Mitochondrial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
- NCT05282654 · 1,300 participants · NA
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI